Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Financial Flexibility Index

Latest as of September 2025: -0.02x

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd financial flexibility index. Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CN¥-9.54 Million (operating CF CN¥-17.57 Million minus capex CN¥8.02 Million) represents 0% of total liabilities (CN¥567.12 Million). Explore 300534 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Financial Flexibility Index

-0.02x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥-9.54 Million
Operating CF − Capex

Total Liabilities

CN¥567.12 Million
CNY

Capital Expenditures

CN¥8.02 Million
CNY

Financial Flexibility Index of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)

Financial flexibility index of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 15 annual periods. Check 300534 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Financial Flexibility Index by Year (2011–2025)

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. For the full cash flow conversion analysis, see Gansu Longshenrongfa Pharmaceutical Indu (300534) cash conversion ratio.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 0.06x CN¥36.83 Million CN¥-6.54 Million CN¥613.42 Million ▼ -83.7%
2024 0.37x CN¥248.36 Million CN¥170.14 Million CN¥674.39 Million ▲ +3.3%
2023 0.36x CN¥222.89 Million CN¥96.53 Million CN¥625.14 Million ▲ +113.0%
2022 0.17x CN¥25.05 Million CN¥11.43 Million CN¥149.66 Million ▼ -70.4%
2021 0.56x CN¥51.55 Million CN¥51.13 Million CN¥91.24 Million ▲ +16.1%
2020 0.49x CN¥62.05 Million CN¥43.50 Million CN¥127.53 Million ▼ -38.9%
2019 0.80x CN¥56.73 Million CN¥28.21 Million CN¥71.26 Million ▲ +253.0%
2018 0.23x CN¥13.01 Million CN¥10.23 Million CN¥57.68 Million ▼ -70.6%
2017 0.77x CN¥53.67 Million CN¥-2.05 Million CN¥70.04 Million ▼ -30.8%
2016 1.11x CN¥66.17 Million CN¥13.14 Million CN¥59.74 Million ▲ +36.8%
2015 0.81x CN¥195.26 Million CN¥30.60 Million CN¥241.17 Million ▼ -32.5%
2014 1.20x CN¥138.36 Million CN¥39.01 Million CN¥115.40 Million ▲ +67.2%
2013 0.72x CN¥96.86 Million CN¥35.92 Million CN¥135.04 Million ▲ +47.7%
2012 0.49x CN¥59.78 Million CN¥35.62 Million CN¥123.07 Million ▲ +63.2%
2011 0.30x CN¥22.37 Million CN¥10.16 Million CN¥75.15 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities